CHC patients. With IFN therapy, ALT levels did not decrease more than 50%, while with IFN combined with SNMC therapy, ALT levels decreased approximately 70% in all patients (one became normal), but no other parameters were changed. Here, IFNA1 is linked to cryohydrocytosis.